Effect of fluoxetinein treatment of vitiligo
Phase 3
Recruiting
- Conditions
- vitiligo.Vitiligo
- Registration Number
- IRCT20221020056251N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Have not received any topical treatment or phototherapy during the past month.
Lack of follicle pigmentation
Absence of white hair in loss
Their lesions should be on the limbs and trunk, except for the ends of the limbs and genitalia and around the nails and folds
The extent of involvement is less than 20% of the total body surface.
No history of any psychiatric disorder
No simultaneous use with monoamine oxidase inhibitor drugs (MAOI)
No history of hypersensitivity reaction to Fluoxetine or any of the compounds in the formulation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The size of the lesion. Timepoint: 3 months after starting treatment. Method of measurement: The surface area of the lesion.
- Secondary Outcome Measures
Name Time Method